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Reduce, Refine, Replace: The Failure of the Three
R's and the Future of Animal Experimentation
Darian M Ibrahimt
The debate in animal ethics is defined by those who advocate
the regulation of animal use and those who advocate its aboli-
tion.' The animal welfare approach, which focuses on regulating
animal use, maintains that humans have an obligation to treat
animals "humanely" but may use them for human purposes.2 The
animal rights approach, which focuses on abolishing animal use,
argues that animals have inherent moral value that is inconsis-
tent with us treating them as property.3
The animal welfare approach is the dominant model of ani-
mal advocacy in the United States.4 Animal experimentation
provides a fertile ground for testing this model because a unique
confluence of factors make experimentation appear susceptible to
meaningful regulation. First, there is more opposition to using
animals in experiments than to any other type of animal use.'
I Associate Professor, University of Arizona James E. Rogers College of Law. My
thanks to David Adelman, Taimie Bryant, Dave Fagundes, Jamie Heisler Ibrahim, Tom
Lindell, Marc Miller, Andrew Rowan, Roy Spece, and participants at the University of
Chicago Legal Forum Symposium, held Oct 28-29, 2005. Special thanks are owed to Gary
Francione. I also thank Nikia Fico and Maureen Garmon for their excellent research
assistance.
1 Consider Gary L. Francione, Rain Without Thunder: The Ideology of the Animal
Rights Movement 1-6 (Temple 1996) (discussing these two basic approaches to animal
advocacy).
2 Id at 1.
3 Id. As Gary Francione discusses, some animal welfare advocates maintain that
regulation is a means to abolition. Francione argues, however, that continuing to regulate
animal exploitation will simply further entrench its acceptability and will not lead to
abolition. Id at 110-41.
4 Francione, Rain Without Thunder at 32 (cited in note 1) ("Although virtually all
modern animal advocates describe their various positions as embodying 'rights' views in
their fund-raising literature and in the media, many leaders of the movement now explic-
itly dismiss the importance of rights notions."); Darian M. Ibrahim, The Anticruelty Stat-
ute:A Studyin Animal Welfare, 1 J Animal L & Ethics 175, 178-79 (2006).
5 See, for example, Andrew N. Rowan, Of Mice, Models, & Men: A Critical Evalua-
tion of Animal Research 31 (SUNY 1984) ("What is it about animal research that pro-
duces such strong reactions? Intensive farming methods, whereby animals are essentially
protein factories, is of concern to animal welfare groups, but the issues does not evoke
nearly as much passion."). Consider Deborah Rudacille, The Scalpel and the Butterfly:
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Second, animal advocates and commercial researchers have
agreed on a common approach for tackling that problem-the
Three R's-which require researchers to reduce the number of
animals used in experiments, refine experimental procedures to
minimize animal pain and suffering, and replace animal subjects
with non-animal alternatives when scientifically feasible.6 Third,
Congress has responded to public concern over animal experi-
mentation by incorporating the Three R's into the federal Animal
Welfare Act ("AWA"), the most significant animal protection law
in the United States.7 The Three R's have also been adopted as
federal policy for biomedical research and toxicity testing.' Fi-
nally, the Three R's provide specific guidance to researchers on
how to implement the widely accepted principle that humans not
inflict "unnecessary" suffering on animals.9 The principle against
unnecessary suffering is contained in all animal protection laws,
including state anticruelty statutes, but only the Three R's make
it context-specific. 10
Given this favorable confluence of factors, it stands to reason
that if the animal welfare approach is to work anywhere, it will
be in the context of animal experimentation. However, this Arti-
cle will show that the Three R's fail to meaningfully regulate
animal experiments. There are three main reasons for this fail-
ure. First, the Three R's do not provide a mechanism for chal-
lenging a researcher's purpose in conducting an experiment that
will use animals, even if that experiment is unnecessary." Sec-
The Conflict Between Animal Research and Animal Protection (Farrar, Straus and
Giroux 2000) (tracing the history of animal experimentation and the opposition of animal
advocates).
6 See Francione, Rain Without Thunder at 85 (cited in note 1) ("The concept of the
'three Rs' is unquestionably an animal welfare concept in that it purports to regard the
exploitation of nonhumans as morally legitimate but subject to some limitation the extent
of which is determined and applied by the scientific community.").
7 7 USC §§ 2131-2159 (2000).
' See Part II.C. Biomedical research focuses on curing human diseases, whereas
toxicity testing is focused on determining the safety of products containing potentially
harmful compounds.
' For a discussion of anticruelty statutes and their deficiencies, see Gary L. Fran-
cione, Animals, Property, and the Law 117-61 (Temple 1995); Gary L. Francione, Intro-
duction to Animal Rights: Your Child or the Dog? 54-73 (Temple 2000); Ibrahim, J Ani-
mal L & Ethics (cited in note 4); David J. Wolfson and Mariann Sullivan, Foxes in the
Hen House: Animals, Agribusiness, and the Law A Modern American Fable, in Cass R.
Sunstein and Martha C. Nussbaum, eds, Animal Rights: Current Debates and New Di-
rections 205, 207-12 (Oxford 2004).
1 See Francione, Introduction to Animal Rights at xxiii (cited in note 9) (stating that
the principle of unnecessary suffering, also called the humane treatment principle, "has
been an entrenched and uncontroversial part of our culture since the nineteenth century.
[it is] not only a moral rule but a legal rule as well").
" See Part III.A.
THE FUTURE OF ANIMAL EXPERIMENTATION
ond, loopholes in the AWA have allowed researchers to avoid ap-
plication of the Three R's in practice. 2 Third, the Three R's were
not designed to apply to new and emerging areas of biomedical
research that have the potential to greatly escalate the use of
animals in experiments."8 These areas include stem cell research,
cloning, xenotransplantation, genetic modification, and bioterror-
ism defense, each of which will be discussed in this Article.
This Article proceeds as follows. Part I gives the basics of the
Three R's and examples of reductions, refinements, and replace-
ments. Part II discusses the general acceptance of the Three R's
by both researchers and animal advocates and the incorporation
of the Three R's into federal law and research policy. Part III ex-
plores the three main deficiencies in the Three R's.
I. BASICS OF THE THREE R's
The Three R's were first proposed by scientists William Rus-
sell and Rex Burch in their 1959 book The Principles of Humane
Experimental Technique.4 Russell and Burch assumed that sci-
entific uses of animals were generally compatible with animal
welfare.' 5 At the outset of their book, they stated:
It has sometimes seemed that there is an irreconcilable
conflict between the claims of science and medicine and
those of humanity in our treatment of lower animals....
The conflict disappears altogether on closer inspection,
and by now it is widely recognized that the humanist pos-
sible treatment of experimental animals, far from being
an obstacle, is actually a prerequisite for successful ani-
mal experiment.16
Russell and Burch did not seek the abolition of animal ex-
perimentation, but only the "removal of [its] inhumanity"
through implementation of the Three R's' 7-a goal consistent
with the animal welfare approach.
Reduce refers to improvements that minimize the total
number of laboratory animals used to obtain a given set of data."
12 See Part III.B.
12 See Part III.C.
14 W.M.S. Russell and R.L. Burch, The Principles of Humane Experimentl Tech-
nique (Methuen 1959).
'5 Id at 3.
's Id at 3-4.
', Id at 64.
18 Russell and Burch, The Principles of Humane Experimental Technique at 64 (cited
in note 14) ("Reduction means reduction in the numbers of animals used to obtain infor-
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Russell and Burch urged the reduction of animal use through
controlling variance and better design and analysis of experi-
ments.19 In terms of variance, they observed that "[i]f every sin-
gle individual (of a species, say) were absolutely identical in all
respects, very few animals would be needed," but that "[i]n the
real world, individual animals do vary."20 To reduce variance,
Russell and Burch suggested using inbred strains of the same
species of animal.2' In terms of experimental design and analysis,
Russell and Burch suggested that researchers consult with stat-
isticians either before or after experimentation.22 Consultation
before experimentation can lead to better design, including use of
the minimum number of animals necessary for statistical analy-
sis and extrapolation purposes, while consultation after experi-
mentation can salvage results of a bad design through the statis-
tical isolation of variance, thereby avoiding repetition of the ex-
periment.2"
Refine refers to improvements that minimize the suffering of
animals that are used in experiments.24 Refinements can be gen-
eral or specific. Russell and Burch described the general refine-
ment of anesthesia as "the supreme refinement procedure."25
Other general refinements include analgesia (local anesthesia),
administering substances through inhalation rather than injec-
tion (to avoid the distress from needles), and restraining animals
after experimentation (to prevent wound licking that could ne-
cessitate repetition of the experiment).2 Specific refinements
mation of given amount and precision.").
19 Id at 105-33.
20 Id at 107.
21 Id at 116-23. In addition to reducing variance, Russell and Burch also observed the
importance of controlling variables, such as animal confinement conditions and room
temperature, that could cast doubt on experimental results. Id at 123-33.
' Russell and Burch, The Principles of Humane Experimental Technique at 111
(cited in note 14) ("Of course it is an elementary principle for an experimenter not himself
a statistician to seek advice before experimenting ... [however] [it certainly is always
possible ... to decide after the event whether enough animals have been used.").
' See id at 110-14 (discussing the design and analysis of scientific experiments). See
also Michael F.W. Festing, Reduction ofAnimal Use: Experimental Design and Quality of
Experiments, 28 Lab Animals 212, 212-13 (1994) (detailing poorly designed and analyzed
animal experiments); R.V. Lenth, Some Practical Guidelines for Effective Sample Size
Determination, 55 Am Statistician 187, 187-93 (2001) (opining that either too small or too
large a sample is economically wasteful; the undersized sample because the results can-
not be used, and the oversized sample because more resources were used than were re-
quired).
' See Russell and Burch, The Principles of Human Experimental Technique at 64
(cited in note 14) ("Refinement means any decrease in the incidence or severity of inhu-
mane procedures applied to those animals which still have to be used.").
25 Id at 137.
26 Id at 137-39.
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include the use of minor paralysis instead of death as an end-
point in some toxicity tests 7 and restricting or eliminating the
use of Complete Freund's Adjuvant, which causes a highly pain-
ful inflammatory reaction, in immunization studies." Improved
living conditions can also reduce distress in laboratory animals,2 9
although Russell and Burch conceded that this was not possible
in large laboratories where "imperfect handling, injection, hous-
ing, and general husbandry become virtually inevitable." 0
Replace refers to the use of a non-animal alternative in place
of an animal during an experiment.3 Replacement techniques
include in vitro studies on human cells and tissues,32 physico-
2 See Rowan, Of Mice, Models, & Men at 264-65 (cited in note 5).
2 See HSUS, Overview of the Issues, available at <http'J/www.hsus.org/web-
files/PDF/ARI/Overview of the Issues.pdf> (last visited Jan 12, 2006) (explaining Com-
plete Freund's Adjuvant). Andrew Rowan suggests, however, that often the painful in-
flammation may be caused by non-sterile conditions rather than by the test itself. E-mail
from Andrew Rowan to Darian Ibrahim (Dec 8, 2005) ("Rowan E-mail") (on file with au-
thor).
2 See, for example, Sarah Wolfensohn, Social Housing of Large 'imates, Methodol-
ogy for Refinement of Husbandry and Management 32 (Supp 1) Alternatives to Lab Ani-
mals 149, 149-51 (2004), available at <http://www.worldcongress.net/2002/proceed-
ings/B2%2OWolfensohn.pdf> (last visited Jan 12, 2006) (proposing to reduce stress in
rhesus monkeys by housing them loose in rooms without cages to promote the develop-
ment of normal social relationships).
30 Russell and Burch, The Pinciples of Humane Experimental Technique at 65 (cited
in note 14).
"' Id at 64 ("Replacement means the substitution for conscious living higher animals
of insentient material."). However, Russell and Burch also deemed replacements to in-
clude "relative replacements," which did not completely eliminate the use of animals. Id
at 70-71 ("[NIon-recovery experiments on living and intact but completely anesthetized
animals" are "beyond reproach" if coupled with euthanasia and reduction.). The different
meanings attached to terms by researchers and animal advocates can result in misper-
ceptions over the amount of animal experimentation that is still occurring. See, for exam-
ple, Rowan, Of Mice, Models, & Men at 261 (cited in note 5) ("[D]ifferent groups use the
term 'alternatives' to refer to different sets of techniques. For example, one group may be
referring to only those techniques that lead to total replacement of laboratory animal use,
while another will include a broader range, such as techniques that reduce animal pain
and suffering."); Rudacille, The Scalpel and the Butterfly at 169 (cited in note 5) (noting
that the use of the word "alternatives" led to a delay in the National Institutes of Health
("NIH") 1994 Plan for the Use ofAnimals in Research, as NIH committee members feared
that this word meant only replacements to animal rights groups, while the committee
also wanted it to incorporate the ideas of reduction and refinement). For a discussion of
how definitions can be used to further animal exploitation, see Taimie L. Bryant, Animals
Unmodified: Defining Animals/Defining Human Obligations Toward Ammals, 2006 U Chi
Legal F 137, 148-62.
32 Russell and Burch counted as replacements in vitro studies made possible by the
killing of animals for their cells and tissues. Michael Balls, Replacement of Animal Pro-
cedures: Alternatives in Research, Education and Testing, 28 Lab Animals 193, 194
(1994). These only constitute true replacements if the cells and tissues come from con-
senting humans, which is increasingly common. See C. Ray Greek and Jean Swingle
Greek, Sacred Cows and Golden Geese: The Human Cost of Expeniments on Animals 102
(Continuum 2000) ("[H]uman cells and tissues, removed during surgery, biopsies, or post-
mortem, can be grown outside the body in a 'test tube' . . . and any types of cells can be
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chemical studies,33 computer modeling,34 microbiological studi-
es, 35 clinical and epidemiological studies,3 6 and autopsy.37 Russell
and Burch discussed the importance of fidelity and discrimina-
tion when analyzing replacements. 38 Fidelity refers to how well a
kept alive almost indefinitely.").
One example of in vitro usage comes from the search for the polio vaccine in the
1950s. Despite the death of over one million monkeys for this purpose, see Rowan, Of
Mice, Models, & Men at 117-20 (cited in note 5), in vitro studies ultimately led to the
development of the polio vaccine. See Francione, Introduction to Animal Rights at 38
(cited in note 9) ("Polio experiments involving monkeys falsely indicated that the virus
affected only the nervous system, and this mistake--directly related to the reliance on
'animal models'-delayed discovery of the polio vaccine."); A. Sabin, Remarks, Statements
before the Subcommittee on Hospitals and Health Care, Committee on Veterans Affairs,
and House ofRepresentatives (Apr 26, 1984) (serial no 98-48) (Testifying under oath, Dr.
Albert Sabin, the inventor of the polio vaccine, stated that the vaccine "was long delayed
by the erroneous conception of the nature of the human disease based on misleading
experimental models of [it] in monkeys"). For further discussion of the development of the
polio vaccine, see Rudacille, The Scalpel and the Butterfly at 98-119 (cited in note 5). For
other examples of in vitro alternatives, see discussion at notes 120-34 and accompanying
text.
" Physiochemical studies have replaced the use of animals in some areas such as in
fat-soluble vitamin assays, but they are more often used as screening tests for detecting
the potential of a substance to be irritating. Animal tests are subsequently performed on
potentially irritating substances. See Rowan, Of Mice, Models, & Men at 262 (cited in
note 5); European Commission Health & Consumer Protection Directorate-General, Opin-
ion of the Scientific Committee on Toxicity, Ecotoxicity and the Environment on The
BUA V-ECEAE Report on "The Way Forward-Action to End Animal Toxicity Testing,"
available at <http:/europa.eu.int/comm/health/ph.risk/committees/sct/documents/out
217_en.pdf> (last visited Jan 10, 2005).
' Computer modeling has been used in many ways, including for "actively designing
drugs and chemicals for specific purposes." Balls, Replacement of Animal Procedures at
196 (cited in note 32). Computer modeling can predict how a human may respond to con-
tact with certain chemicals by using mathematical algorithms and data from both human
exposure and previous animal studies. See, for example, National Institutes of Environ-
mental Health Sciences, Factsheet: NIEHS and the Use of Alternative Methods in Toxico-
logical Research and Testing, available at <http://www.niehs.nih.gov/oc/fact-
sheets/analt.htm> (last visited Feb 27, 2006).
"5 Microbiological systems can serve as models of more complex systems and have
completely replaced the need for animals in some cases by using bacteria to detect the
presence of particular vitamins, mutagens, and even carcinogens. See, for example,
Rowan, Of, Mice, Models, & Men at 263 (cited in note 5). See also Russell and Burch, The
Principles of Humane Experimental Technique at 98-104 (cited in note 14).
" Epidemiological studies focus on the distribution and determination of disease in
human populations to control health problems. By concentrating research on human
patients, volunteers, or populations, the results obtained from these studies are often far
more relevant than those obtained from animal studies. Rowan, Of Mice, Models, & Men
at 264 (cited in note 5).
"' Autopsies are often neglected as an alternative to animal experimentation despite
being an important means of studying the effects of an illness on the whole body. See
David Dobbs, Buried Answers, NY Times 6-40 (Apr 24, 2005) (critiquing the underuse of
autopsies as a means of studying human diseases); Americans, Europeans, Japanese for
Medical Advancement, Replacing Animals, available at <http://www.curedisease.com/
replacing-animals.pdf> (last visited Jan 10, 2006) ("Virtually every disease has either
been discovered or clarified as a result of autopsy.").
I Russell and Burch, The Principles of Humane Experimental Technique at 77-84
(cited in note 14). See also Rowan, Of Mie, Models, & Men at 265 (cited in note 5) (stat-
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replacement replicates the original in an overall sense; discrimi-
nation refers to how well a replacement represents the original
in terms of a particular property of interest to researchers. For
example, a chimpanzee is a high fidelity model of a human, while
a "protozoan is a very low-fidelity model, but it may be a better
model in some studies-for example, vitamin assays-because of
its... discrimination." 9 Russell and Burch argued that "in many
fields, discrimination is recognized in practice to be the more de-
sirable quality,"4 ° and thus referred to the tendency of research-
ers to insist upon a high-fidelity model in all cases as the "high-
fidelity fallacy."41
II. ACCEPTANCE OF THE THREE R's AS FEDERAL LAW AND
RESEARCH POLICY
A. Acceptance of the Three R's by Animal Welfare Advocates
and Commercial Researchers
Many large animal welfare organizations and prominent
animal advocates support the Three R's. Organizational support-
ers include the Humane Society of the United States ("HSUS"),42
the American Society for the Prevention of Cruelty to Animals
("ASPCA"), 4  and the American Anti-Vivisection Society
("AAVS").' HSUS, for instance, gives a "Russell and Burch
Award" to "a scientist who has made an outstanding contribution
ing that considerations of fidelity and discrimination are "most important when discuss-
ing the relative merits of alternatives and animal models").
"9 Rowan, OfMice, Models,& Men at 265-66 (cited in note 5).
'o Russell and Burch, The Principles ofHumane Experimental Technique at 79 (cited
in note 14).
41 Id at 80-84.
42 See HSUS, Current Projects of the Animal Research Issues Section, available at
<httpJ/www.hsus.orglanimals-in research/general-information onanimalresearch/curr
ent-projects-of theanimalresearchissuessection.html> (last visited Jan 12, 2006).
The primary aim of The HSUS's Animal Research Issues section is to promote alterna-
tives to the use of animals in harmful research, testing, and education. Alternatives are
scientific methods that accomplish one or more of the Three R's: replace or reduce the use
of animals in a scientific procedure, and/or refine a procedure so the animals experience
less pain, suffering or discomfort.
HSUS is the world's largest animal welfare organization, with approximately three
and a half million members. Rudacille, The Scalpel and the Butterfly at 294 (cited in note
5).
41 See Stephan L. Zawistowski, Operation: Three Rs (ASCPA 1996), available at
<http://www.aspca.org/site/PageServer?pagename=al-resourcesoperation> (last visited
Jan 12, 2006) ("Our recent efforts have followed the 3Rs theme that guides the movement
today-to reduce, refine, and replace the use of animals in research.").
" See AAVS, The Three R's, available at <httpJ/aavs.org/alternatives01.html> (last
visited Jan 12, 2006) (promoting the Three R's). AAVS describes itself as "the oldest or-
ganization in the United States dedicated to eliminating experiments on animals." Id.
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towards advancing the Three R's."a" Deborah Rudacille notes
that even "PETA, the perceived archnemesis of the research
community.., attended an FDA meeting on alternative testing,
sitting around the table with FDA officials and representatives of
Colgate-Palmolive Company to discuss possible areas for coop-
eration."46 Individual supporters include Andrew Rowan, an Ex-
ecutive Vice President of HSUS, who argues in favor of collabora-
tion with researchers to improve animal welfare through imple-
mentation of the Three R's.47 Another individual supporter of the
Three R's was Henry Spira, one of the most influential animal
advocates of the past century,48 who stated that "what's practical
and doable is the concept of the Three R's. I don't believe that
there's anyone who can rationally or reasonably make a dent in
the Three R's. That's something that is unassailable, I believe."49
While the Three R's are now seen by many animal advocates
as an important means of reducing animal suffering, they were
largely ignored at first. According to Rudacille, "[a]lthough cer-
tain people... had continued to promote the ideas advocated by
Russell and Burch .. .throughout the sixties and seventies, for
the most part the book remained obscure until a new generation
41 See HSUS, Van Zutphen Wins 2005 Russell and Burch Award, available at
<http://www.hsus.org/animals in-research/general-information on-animalresearch/the_
russell and burch-award> (last visited Feb 27, 2006) ("The Russell and Burch award is
bestowed every few years by The Humane Society of the United States to a scientist who
has made an outstanding contribution toward advancing the Three Rs of replacement,
reduction and refinement of animal use in research."); Rudacille, The Scalpel and the
Butterfly at 294 (cited in note 5) ("The Humane Society of the United States... awards
certificates each year to scientists who have made outstanding contributions toward the
advancement of alternative methods in research, education, and testing.").
46 Rudacille, The Scalpel and the Butterfly at 184 (cited in note 5).
4 See Rowan, Of Mice, Models, & Men at 261-73 (cited in note 5); Andrew Rowan,
The Alternatives Concept, available at <http://www.nal.usda.gov/awicalternatives/
rowan.htm> (last visited Jan 12, 2006). Some abolitionists believe that all animal re-
search should stop today while others are willing to be more pragmatic. Most animal
welfare supporters would like to see the end of animal use in research but do not perceive
this to be a realistic or practical goal at the moment. Instead, they believe that the re-
search establishment should devote more time and money to finding ways to eliminating
animal pain and distress in research techniques (in other words, the three R's-
Reduction, Refinement, and Replacement).
48 See Francione, Rain Without Thunder at 85 (cited in note 1) (stating that Spira "is
thought to be one of the most influential [animal advocates] of this century").
" Id at 86, quoting interview with Henry Spira, Foundation for Biomedical Research
Newsletter (Jan/Feb 1993). Spira sought to abolish animal exploitation, but viewed regu-
lation as a means to that end. Francione, Rain Without Thunder at 62 (cited in note 1)
("Spira concluded that his abolitionist efforts up until 1979, although highly successful,
were 'largely symbolic, involving a few thousand animals.' He became willing to reform
institutionalized cruelty. Spira adopted a more welfarist approach in undertaking a more
ambitious project-the use of animals in cosmetics and product testing.") (citation omit-
ted).
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grasped its relevancy to the testing controversy."50 Since then,
"the three R's approach has spread throughout the industry,
regulatory agencies, and the research community, giving scien-
tists and animal protectionists a common language and a vehicle
for identifying common goals."5 According to Rowan, the "key is
that the idea of 'alternatives' offers a pro-science notion of grad-
ual reform and is therefore not inimical to biomedical research."52
Among the research community, the Foundation for Bio-
medical Research ("FBR"), "the nation's oldest and largest or-
ganization"53 advocating for the use of animals in experiments,
purports to accept the Three R's.54 FBR claims that:
Here in the United States, our scientific and medical re-
search communities are committed to supporting the de-
velopment of research techniques that reduce the number
of animals used in each and every study, replace lab ani-
mals with non-animal models whenever possible, [and] re-
fine the tests to ensure the most comfortable and humane
conditions possible.55
Many large corporations that use animals for biomedical re-
search and product testing proffer similar support for the Three
R's. 6 Even Charles River Laboratories, the world's largest com-
o Francione, Rain Without Thunder at 167 (cited in note 1). See also Balls, Replace-
ment of Animal Procedures at 194-96 (cited in note 32) (discussing events that led to the
widespread acceptance of the Three R's).
51 Rudacille, The Scalpel and the Buttertly at 184 (cited in note 5).
52 Rowan, Of Mice, Models, & Men at 59 (cited in note 5).
FBR, About FBR: FBR's Position on Animal Research, available at
<httpJ/www.fbresearch.org/about/position.htm> (last visited Feb 27, 2006).
' See id (discussing FBR's concern for the conditions under which animals are stud-
ied and need for humane experimentation). See also Rudacille, The Scalpel and the But-
terfly at 170 (cited in note 5) (noting that FBR represents "more than three hundred
research institutions and companies"). See also Francione, Rain Without Thunder at 29-
30 (cited in note 1) ("[Tlhe Foundation for Biomedical Research (FBR) and its lobbying
arm, the National Association for Biomedical Research (NABR)... are heavily supported
by commercial animal users and suppliers.., as well as universities and individuals who
use animals.").
5' FBR, Three Rs, available at <httpJ/www.fbresearch.org/education/3rs.htm> (last
visited Jan 12, 2006).
'6 See, for example, GlaxoSmithKline, Animal Research, available at
<httpJ/www.gsk.com/corporate-responsibility/cr-report -2004/ri-animal-research.htm>
(last visited Jan 12, 2006) ("GSK is committed to the 3Rs-reduction, refinement and
replacement-and to achieving the highest standards of animal welfare."); Abbott, Global
Citizenship: Managing Our Key Issues, available at <http'J/abbott.com
/citizenship/citizenabbott/position.cfm> (last visited Jan 12, 2006) ("Abbott's approach is
to employ the '3Rs' whenever possible, which include refining experimental procedures to
avoid or minimize unnecessary pain or suffering; reducing the number of animals used in
any tests we conduct to the minimum to get valid results; and replacing the need for
animal testing through alternative research methods."); Johnson & Johnson, Social Re-
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mercial breeder of animals for sale to laboratories, claims to
"fund[] organizations and projects that... advance the three R's
of animal welfare."57 An exception to this unity of support for the
Three R's among researchers comes from the academic research
community, which is still resistant to the concept and instead
favors unfettered research on animals.5"
B. The Three R's as Federal Law: The Animal Welfare Act
In 1985, the growing power of the animal rights movement,
the documentation of egregious abuses of animals at several re-
search institutions, and the general acceptance of the Three R's
by advocates and researchers prompted Congress to incorporate
the Three R's into the AWA.59 Congress originally passed the
AWA (first called the Laboratory Animal Welfare Act) in 1966
due to growing concern over the theft of family pets for sale to
laboratories, which was detailed by a Life magazine story that
included shocking pictures of how these animals were being kept
by dealers.6 ° Since its enactment, Congress has amended the
sponsibility: Laboratory Research Animal Testing, available at
<http'j/www'jnj.com/cominunity/policies/animal-testing/animal-testing.htm> (last visited
Jan 12, 2006) ("Johnson & Johnson as a corporation is committed to the '3R' principles of
replacement, refinement and reduction of laboratory research animal testing and to seek-
ing alternatives through internal efforts as well as by supporting studies at outside re-
search facilities."); Proctor & Gamble, Animal Alternatives: Product Safety Testing, avail-
able at <http'//www.pg.com/science/aa safety.jhtml> (last visited Jan 12, 2006). Proctor &
Gamble state:
At Procter & Gamble, it is important to us to ensure the safety of our products....
Years ago, animal testing was the primary and most reliable way to confirm the
safety of new ingredients and products. Not anymore. Today, the need for animal
testing has been greatly reduced by our increased use of historical data, the in-
creased sophistication of computer models, and the development of alternative re-
search methods that reduce, refine, or replace animal tests. Id.
"' Charles River Laboratories, The Charles River Laboratories Foundation, available
at <http.//www.criver.com/about-charlesriver/humane-care-initiative/foundation.html>
(last visited Jan 12, 2006).
' See Rudacille, The Scalpel and the Butterly at 169 (cited in note 5) ('The academic
research community was more resistant and to this day is unhappy about the term 'alter-
natives' and only marginally more satisfied with the idea of the 3R's."). According to
Rowan, "[t]oxicologists and the corporate world have embraced the 3Rs but academic
researchers... have not." Rowan E-mail (cited in note 28).
51 See Francione, Rain Without Thunder at 89-90 (cited in note 1) (discussing com-
peting positions on the composition of the AWA amendments); Francione, Animals, Prop-
erty, and the Law at 195-96 (cited in note 9) (stating that the 1985 amendments were the
"result of various cases in which federally funded research facilities were shown to be
involved in the egregious abuse of animals" and represent "the only really substantial
revision of the AWA since its enactment"). The amendments to the AWA that incorpo-
rated the Three R's are discussed in notes 63-74.
6 This prompted Senator Robert Dole to refer to this legislation as the "dognapping
bill of 1966." 116 Cong Rec 40, 461 (1970) (statement of Senator Dole). According to Fran-
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AWA five times for reasons including expanding its scope.6 The
most significant amendments came in 1985, when Congress in-
corporated the Three R's into the AWA in several ways. First,
although the original purpose of the AWA was to prevent pet
theft, the 1985 amendments added the following policy language:
Congress finds that.., methods of testing that do not use
animals are being and continue to be developed which are
faster, less expensive, and more accurate than traditional
animal experiments for some purposes and further oppor-
tunities exist for the development of these methods of
testing, [and] measures which eliminate or minimize the
unnecessary duplication of experiments on animals can
result in more productive use of Federal funds.62
This language emphasized the newfound importance of the Three
R's in animal ethics.
Second, the body of the AWA was revised to include the
Three R's in several specific provisions. One such provision re-
quires the Secretary of Agriculture to promulgate "minimum re-
quirements ... for the use of tranquilizers, analgesics, and anes-
thetics" in "any practice which could cause pain to animals"" (in
other words, procedures classified as category "D" and "E" stud-
ies by USDA), although it also allows researchers to withhold
pain relief when "scientifically necessary."' A similar provision
mandates "that animal pain and distress are minimized, includ-
ing adequate veterinary care with the appropriate use of anes-
thetic, analgesic, tranquilizing drugs, or euthanasia. " " These are
clear examples of refinements. The ideas of replacement and re-
duction were also apparent after the 1985 amendments. For in-
stance, one provision requires the Secretary to promulgate
cione, "[c]oncerned persons sent more letters to Life than the magazine had received on
any other article, and sent more letters to Congress than were sent on issues such as civil
rights and the war in Vietnam." Francione, Animals, Property, and the Law at 192 (cited
in note 9) (Feb 4, 1966 Life magazine on file with author).
61 The AWA was amended in 1970, 1976, 1985, 1990, and 2002. For a discussion of
the AWA and its history through the 1990 amendments, see Francione, Animals, Prop-
erty, and the Law at 185-249 (cited in note 9).
62 Food Security Act of 1985, 7 USC § 2143(aX3) (2000).
6 7 USC § 2143(a)(3)(C)(v) (2000) (emphasis added). A requirement to use anesthet-
ics was first added in the 1970 amendments to the AWA. See Pub. L No 91-579 (Dec 24,
1970) (amending § 13 of 7 USC § 2143 to read: "Such standards [governing research fa-
cilities] shall include.., adequate veterinary care, including the appropriate use of anes-
thetic, analgesic or tranquilizing drugs, when such use would be proper in the opinion of
the attending veterinarian of such research facilities. . .
4 7 USC § 2143(a)(3)(A) (2000).
6 7 USC § 2143(a)(3)(B) (2000).
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"minimum requirements ... that the principal investigator con-
siders alternatives to any procedure likely to produce pain or dis-
tress in an experimental animal,"66 while another provision
mandates that the Secretary to establish an information service
at the National Agricultural Library67 to provide information on
methods that can "reduce or replace animal use; and minimize
pain and distress to animals."6"
Third, the AWA and its implementing regulations were
amended to require that research facilities establish Institu-
tional Animal Care and Use Committees ("IACUCs") to imple-
ment the Three R's.69 The AWA requires that IACUCs have at
least three members, one of whom cannot be affiliated with the
research facility.7" IACUC members must review the research
66 7 USC § 2143(e)(3) (2000) (emphasis added). See also Paul A. Locke, Presentation,
The Animal Welfare Act and the 3Rs- Where are We and Where Should We Go?(Sep 10,
2001), available at <http//caat.jhsph.edu/programs/workshops/20th/locke.htm> (noting
that the 1985 amendments to the AWA added a provision mandating that alternatives be
considered "if a procedure involves pain and distress" in an effort to strike a balance
between the necessity of biomedical research and animal welfare).
67 For information on the National Agricultural Library, see
<http://www.nal.usda.gov/> (last visited Jan 12, 2006).
68 7 USC § 2143(b) (2000).
69 7 USC § 2143(b)(1)(B) (2000). Specifically, the AWA's implementing regulations
require IACUCs to ensure that:
[P]roposed activities or significant changes in ongoing activities meet the following
requirements:
(i) Procedures involving animals will avoid or minimize discomfort, dis-
tress, and pain to the animals;
(ii) The principal investigator has considered alternatives to procedures
that may cause more than momentary or slight pain or distress to animals,
and has provided a written narrative description of the methods and
sources, e.g., the Animal Welfare Information Center, used to determine
that alternatives were not available;
(iii) The principal investigator has provided written assurance that the ac-
tivities do not unnecessarily duplicate previous experiments.
9 CFR § 2.31(d) (2005). IACUCs are somewhat similar to the Institutional Review Boards
("IRBs") that oversee experiments on humans. See 45 CFR §§ 46.101 (2005). However,
there is a fundamental difference between animal experimentation and human experi-
mentation, and therefore between the functions of IACUCs and IRBs. In the former,
animals are used in experiments against their will; in the latter, we require humans used
in experiments to have given informed consent. Informed consent is the primary safe-
guard for ensuring that humans are not used in unnecessary experiments, and this safe-
guard is absent in animal experiments. There are certain deviations from or exceptions to
the informed consent paradigm for humans-for example, surrogate consent and rare
contexts in which consent is deemed unnecessary. See 45 CFR § 46.116(c-d); Carl H.
Coleman, et al, The Ethics and Regulation of Research with Human Subjects 527-650
(Lexis 2005). Nevertheless, informed consent is the central governing concept in legal and
moral analyses of human experimentation.
70 9 CFR § 2.31(b)(3) (2005).
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facility's program on animal welfare and inspect its facilities
every six months.71 They must prepare reports on their findings
which "shall be reviewed and signed by a majority of the IACUC
members and must include any minority views. " " The main
function of IACUCs is to reduce pain and distress, although
IACUC approval is not required for experiments that are classi-
fied as unlikely to cause more than minor pain and distress.
Rowan estimates that these category "C" experiments comprise
approximately 60% of all experiments.7"
Finally, the AWA also requires that research facilities them-
selves submit an annual report that "[a]ssure[s] that each prin-
cipal investigator has considered alternatives to painful proce-
dures" and reports on painful experiments, both those that in-
volved the use of pain-relieving drugs and those that did not.74
C. The Three R's as Federal Research Policy
The Three R's are also prevalent in federal research policy.
Many research facilities receive funding from the Public Health
Service ("PHS") or its agency the National Institutes of Health
("NIH"). These facilities must comply with the PHS Policy on
Humane Care and Use of Laboratory Animals76 and the NIH
Guide for the Care and Use of Laboratory Animals, 76 both of
which incorporate the Three R's.77 The policies require IACUCs
71 9 CFR § 2.31(c)(1)-(2) (2005).
72 9 CFR § 2.31(c)(3) (2005).
73 Rowan E-mail (cited in note 28). Category C studies can include those that involve
overnight food or water deprivation, as well as surgery under anesthesia that may in-
clude minimal post-surgical pain and distress.
74 9 CFR § 2.36(b)(2) (2005).
" Office of Laboratory and Animal Welfare/National Institutes of Health, Public
Health Service Policy on Humane Use of Laboratory Animals 7 (NIH 2002) ("PHS Policy")
("This Policy is applicable to all PHS-conducted or supported activities involving animals,
whether the activities are performed at a PHS agency, an awardee institution, or any
other institution and conducted in the United States.").
" National Academy of Sciences ("NAS"), Introduction, Guide for the Care and Use of
Laboratory Animals (Natl Academy 1996), available at <http'J/www.nap.edu/readin-
groomlbooks/labrats/introduction.html> (last visited Jan 15, 2006) (hereinafter NAS
Guide). The NAS Guide is incorporated by reference into the PHS Policy.
" See PHS Policy at 15-16 (cited in note 75) (noting that institutions applying for
funds from PHS must specify a "rationale for involving animals, and for the appropriate-
ness of the species and numbers used" and "a description of procedures designed to assure
that discomfort and injury to animals will be limited to that which is unavoidable in the
conduct of scientifically valuable research, and that analgesic, anesthetic, and tranquiliz-
ing drugs will be used where indicated and appropriate to minimize discomfort and pain
to animals"); NAS Guide at 10 (cited in note 76) (stating that protocols include considera-
tion of "[a]vailability or appropriateness of the use of less-invasive procedures, other
species, isolated organ preparation, cell or tissue culture, or computer simulation," em-
ploying "[a]ppropriate sedation, analgesia, and anesthesia," and avoiding "[u]nnecessary
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to have at least five members, one of whom cannot be affiliated
with the research facility and one of whom has "primary con-
cerns . . . in a nonscientific area (for example, ethicist, lawyer,
member of the clergy).""8 They also require IACUCs to review
research facility programs on animal welfare, inspect research
facilities, and submit reports on both.79
Federal agencies that oversee toxicity testing on consumer
products have also begun to adopt the Three R's, albeit more
slowly. Agencies including the Environmental Protection Agency
("EPA"), the Food and Drug Administration ("FDA"), the Con-
sumer Product Safety Commission ("CPSC"), and the Occupa-
tional Safety and Health Administration ("OSHA") have tradi-
tionally relied on animals to test the toxicity of various sub-
stances.8 " For example, the EPA requires animal testing for sub-
stances classified as "pesticides" under the Toxic Substances
Control Act, l and the CPSC requires animal testing to deter-
mine whether substances must be labeled as "highly toxic" under
the Federal Hazardous Substances Act.8 2
Some signs show that these agencies are becoming more re-
ceptive to the Three R's. Certain EPA regulations now explicitly
allow for alternative tests that can reduce the number of animals
used to determine toxicity, 3 and the FDA does not require the
duplication of experiments"). The Principles for the Utilization and Care of Vertebrate
Animals Used in Testing, Research, and Education, which are a part of the PHS Policy
and NIH Guide, also require adherence to the Three R's.
s PHS Policy at 11 (cited in note 75).
9 Id at 12.
80 For an overview of federal toxicity testing laws, consider Megan Erin Gallagher,
Tomcity Testing Requirements, Methods and Proposed Alternatives, 26 Environs Envir L
& Pol J 253 (2003).
81 15 USC § 2603(b)(2)(A) (1996). See also 40 CFR § 799.9110 (2005) (oral toxicity test
requiring the use of animals); 40 CFR § 799.9120 (dermal toxicity test requiring the use
of animals); 40 CFR § 799.9130 (inhalation toxicity test requiring the use of animals).
82 15 USC § 1261(h)(1) (1993).
' See, for example, 40 CFR § 799.9110(d)(1) (2005) ("EPA will accept the following
procedures to reduce the number of animals used to evaluate acute effects of chemical
exposure while preserving its ability to make reasoned judgments about safety."). A rele-
vant proposal is EPA's recent High Production Volume ("HPV") Challenge Program. This
program was a response to an EPA study finding that very little toxicity information was
available on most chemicals manufactured in the U.S. in amounts in excess of one million
pounds a year ("HPV chemicals"). The program encouraged manufacturers to perform
testing on all HPV chemicals they produced, with a goal of having all HPV chemicals
tested by 2005. Those HPV chemicals that were not tested under the program would be
subject to the testing requirements promulgated under § 4 of the Toxic Substances Con-
trol Act. EPA, Report on the Chemical Right-to-Know Workshop (Dec 16-17, 1998), avail-
able at <http'//www.epa.gov/chemrtk/worksumf.htm> (last visited Feb 24, 2006). Initially,
the EPA developed the program without concerns for animal welfare issues, but when the
program was publicly announced in 1998, animal activists and scientists voiced concerns
to the EPA, Congress, and other decisionmakers. In response, the Center for Alternatives
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the Three R's, in 1997 the NIH Director established the Inter-
agency Coordinating Committee on the Validation of Alternative
Methods ("ICCVAM"), which Congress made permanent by the
ICCVAM Authorization Act of 2000.5 ICCVAM is comprised of
the heads of 15 federal regulatory and research agencies, includ-
ing the heads of the EPA, FDA, CPSC, and OSHA.86 Among
ICCVAM's purposes are to "reduce, refine, or replace the use of
animals in testing, where feasible." 7 ICCVAM reviews and
evaluates alternative test methods by convening peer-review
panels composed of scientific experts, who then deliberate over
an alternative in public sessions.88 Public comments are also al-
lowed, after which ICCVAM makes recommendations to federal
agencies regarding the suitability of the alternative.89 Impor-
tantly, however, the agencies retain complete discretion over
whether to accept the alternative recommended by ICCVAM,
although they must provide written justification for a decision to
reject an ICCVAM-approved alternative.9 °
III. MAJOR DEFICIENCIES OF THE THREE R's
Despite their mutual acceptance by adversaries in the fight
over animal experimentation, and despite their status as federal
law and research policy, the Three R's suffer from at least three
to Animal Testing at John Hopkins University held a series of workshops to determine
how the principles of the Three R's could be applied to the program. "This attention cul-
minated in an agreement in which the EPA pledged to make several changes in the HPV
program that would lead to a substantial reduction in animal use." Martin L. Stephens,
et. al, Possibilities for Refinement and Reduction: Future Improvements Within Regula-
tory Testing, 43 ILAR J 74, 76 (2002).
' FDA Release, Animal Testing (June 9, 2005), available at
<http'J/www.cfsan.fda.gov/-dms/cos-205.html> (last visited Jan 12, 2006) (stating that
the Food, Drug, and Cosmetic Act does not require the use of animals to test cosmetics for
safety, although the FDA encourages "appropriate and effective" testing of products).
85 42 USC § 201 (2000).
6 Operational support for ICCVAM is provided by the National Toxicology Program
Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).
For more information about ICCVAM and NICEATM, see <http-//iccvam.niehs.nih.gov/>
(last visited Jan 12, 2006).
87 42 USC § 2851-3(b)(5) (2000). As Rudacille notes, "ICCVAM addresses testing and
not basic research." Rudacille, The Scalpel and the Butterfly at 303 (cited in note 5) (em-
phasis added).
I NIEHS, About ICCVAM? Overview, available at <http-//iccvam.niehs.nih.gov/
about/overview.htm> (last visited Jan 12, 2006).
" See id.
90 42 USC § 2851-5(b) (2000) ("Nothing in this Act shall prevent a Federal agency
from retaining final authority for incorporating the test methods recommended by
ICCVAM in the manner determined to be appropriate by such Federal agency or regula-
tory body.").
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main deficiencies that render them largely ineffective in regulat-
ing laboratory animal use.
A. The Three R's Do Not Allow for Challenges to the Purpose of
Experiments
The first main deficiency of the Three R's is that, despite
their goal of preventing the unnecessary suffering of laboratory
animals, they were not designed to allow for challenges to the
purpose of experiments that will use animals. Instead of chal-
lenging experimental purpose, the Three R's are designed to ac-
cept that purpose, whatever it may be, and simply ask whether
the use of animals can be rendered less frequent through a re-
duction, less painful through a refinement, or replaceable by a
non-animal alternative. But suppose that for a given experiment
many animals are needed, pain relief cannot be provided, and a
non-animal alternative cannot be used. Further suppose that the
necessity or usefulness of the experiment is questionable.9' If the
Three R's are meant to prevent unnecessary animal suffering,
should they not allow an IACUC to prevent this experiment from
taking place? The Three R's stop short of making such an allow-
ance.
A concrete example will help to illustrate this point. Assume
that researchers wish to determine the effect of pain on a given
human behavior-for example, whether human burn victims lose
their appetites. To test this, they design an experiment using
pigs as models for humans. They tie down and blowtorch the
pigs, who are not given pain relief, over a large portion of their
bodies. They then leave the wounds untreated for several days to
observe the pigs' eating habits. These facts are based on actual
experiments said to have been performed and paid for with fed-
eral research funds.92
For this and other experiments, the Three R's can be
thought of in three ways: in their original form as a non-legal,
guiding concept for researchers; as a legal mandate of the AWA;
and as a regulatory measure implemented by federal agencies in
9' For more discussion on the idea of "necessity" in this context, see Office of Technol-
ogy Assessment Publication, Alternatives to Animal Use in Research, Testing, and Edu-
cation 80-81 (GPO 1986).
92 See Francione, Animals, Property, and the Law at 172 (cited in note 9) (discussing
these experiments). Even if these experiments occurred before the 1985 amendments to
the AWA, the amendments did nothing to change the status quo regarding purpose chal-
lenges, and therefore the same experiments could be performed today. See notes 96-99
and accompanying text.
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conjunction with ICC VAM. As a nonlegal mechanism as devel-
oped by Russell and Burch, the Three R's provide no guiding
principles for the burn experiment or other pain experiments.
The researchers have decided to test the effect of pain, so refine-
ments in the form of pain relief are not possible without hinder-
ing the success of the experiment. A non-animal alternative can-
not replace the complex physiological and sensory workings of a
sentient animal, so replacements are not possible either. And
while some reductions may be possible if the experiment would
use an excess number of pigs, researchers must necessarily burn
some pigs. The Three R's would need an additional mechanism-
one that allowed for challenges to experimental purpose to pre-
vent experiments such as these on the grounds that they are
trivial, unnecessary, or of insufficient utility to justify animal
suffering. The literature contains numerous examples of bizarre
and shocking experiments that the Three R's were not designed
to reach.9"
Implemented as a legal mechanism through the AWA, the
Three R's are also unable to prevent the burn experiment or
other pain experiments-an observation previously made by
Gary Francione. 4 On the one hand, the AWA requires research-
ers who seek to perform painful experiments on animals to con-
firm to IACUCs that they will provide pain relief and have con-
sidered non-animal alternatives.95 On the other hand, the AWA
explicitly deprives IACUCs of the ability to challenge experimen-
tal purpose.96 Specifically, the AWA states that IACUCs cannot
challenge the "design, performance, or conduct of actual research
9 See, for example, Animal Welfare Institute, Beyond the Laboratory Door 121-250
(1985) (reviewing the experiments detailed in scientific literature from 1978-1984 that
"by design inflict great suffering of many kinds on a variety of animal species"); Peter
Singer, Animal Liberation 80-81 (NY Rev 3d ed 2002) (describing the experiments that
Thomas Gennarelli conducted at the University of Pennsylvania on monkeys, who were
seen during these experiments "writhing, apparently coming out of anesthesia, as sur-
geons were operating on their exposed brains"). While Singer describes experiments that
predominantly occurred before the 1985 amendments to the AWA, the point remains that
without allowing purpose challenges, the Three R's could not prevent such experiments if
a researcher chose to perform them today. See notes 96-99 and accompanying text.
4 Francione, Animals, Property, and the Law at 172 (cited in note 9) ("[W]hether to
use animals at all, and what limits should be placed on the types of experiments that may
be done... are, for all intents and purposes, not addressed by the law."); id at 200 ("[T]he
AWA plainly states that it is legitimate-and perhaps morally obligatory-to use animals
in experiments. The AWA also states that there are no limits placed on the permissible
use of animals on the basis of experiment content or conduct.").
9 See notes 63-74 and accompanying text.
6 Many animal advocates view IACUCs as important bodies despite this omission.
See Francione, Animals, Property, and the Law at 203 (cited in note 9) ("[I]t is clear that
most legal reformers have placed a great deal of emphasis on the IACUC.").
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or experimentation,"97 and the Secretary of Agriculture is prohib-
ited from "promulgat[ing] rules, regulations, or orders with re-
gard to the performance of actual research or experimentation by
a research facility as determined by such research facility."9"
Consequently, IACUCs cannot ask whether an experiment is
trivial, unnecessary, or likely to cause animal suffering that out-
weighs human benefits.99 Asking these questions might prevent
many biomedical experiments, especially in the category of basic
research. 00
Implemented as a regulatory mechanism, the Three R's are
even less effective in preventing unnecessary animal suffering.
" 9 CFR § 2.31(a) (2005) (The Chief Executive Officer of the research facility shall
appoint an Institutional Animal Care and Use Committee (IACUC), qualified through the
experience or expertise of its members to assess the research facility's animal program,
facilities, and procedures. Except as specifically authorized by law or these regulations,
nothing in this part shall be deemed to permit the Committee or IACUC to prescribe
methods or set standards for the design, performance, or conduct of actual research or
experimentation by a research facility.) (emphasis added).
98 7 USC § 2143(a)(6)(A)(ii).
9 See Singer, Animal Liberation at 79 (cited in note 93) (Amendments to the [AWA]
in 1985... failed to deal with the real issue of control over what happens during an ex-
periment. The amendments set up institutional animal committees, but in keeping with
the unchanged exemption from interference given to the experiments themselves, these
committees have no authority over what goes on in the experiments.).
Rowan claims that some IACUC members do believe they have the power to chal-
lenge experimental purpose, although this seems to be in clear contradiction with the
language of the AWA. Rowan E-mail (cited in note 28).
100 Basic research (also called fundamental or pure research) refers to research for
purposes of advancing knowledge for its own sake, which has no ready aim or application.
Applied research, on the other hand, refers to research undertaken to solve a specific,
practical problem. See Lawrence Berkeley National Laboratory, Basic v. Applied Re-
search, available at <http'//www.lbl.gov/Education/ELSI/research-main.html> (last vis-
ited Jan 5, 2006). Most scientific organizations consider basic research to be at least as
important, if not more important, than applied research. See, for example, America's
Basic Research: Prosperity Through Discovery, available at <http/www.aaas.org/spp
/yearbookichapl8.htm> (last visited Jan 5, 2005) (attributing the remarkable scientific
progress which defined the 20th century to basic research); Jim Morris, Basic Scientific
Research is Our Future, available at <http'//www.scitechantiques.com/ basici> (last
visited Apr 13, 2006) ("[Basic research is] one of the most reliable tools for building civi-
lized civilizations. It gives us the why and how of things."); National Institute of General
Medical Sciences, Cutiosity Creates Cures; The Value and Impact of Basic Research,
available at <http'//publications.nigms.nih.gov/curiosity> (last visited Apr 13, 2006) (stat-
ing that basic research studies 'may not have an immediate impact on our health, yet
that such 'untargeted' research often leads to new medicines, technologies, and research
tools").
It could be argued that pre-determining necessity in basic research is impossible,
yet because even one experiment may turn out to be beneficial for humans, any amount of
animal suffering for the sake of basic research should be allowed. C. R. Gallistel, The
Case for Unrestricted Research Using Animals, Am Psychologist 36(4), 357-62 (1981). If
this argument is accepted, however, it is clear that despite our near-universal proclama-
tions, we do not in fact accept the principle against unnecessary suffering in the context
of experimentation, as any amount of animal suffering could be justified for little or no
human benefit.
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This is due to the even weaker claims of "necessity" present in
most toxicity testing. While popular opinion is generally more
accepting of using animals in biomedical experiments aimed at
curing serious human diseases, it is far less accepting of using
animals to test the toxicity of consumer goods such as cosmetics
and laundry detergents.' 01 Yet the ICCVAM and agency regula-
tions, which together comprise the regulatory implementation of
the Three R's, provide no mechanism for challenging purpose in
toxicity testing. No regulatory body is allowed to ask whether
consumer product tests are trivial, unnecessary, or likely to
cause animal suffering that outweighs human benefits. If pur-
pose could be challenged in this context, many toxicity tests
might be prevented, as they cause significant animal suffering
yet result in trivial human benefits-for example, a "new and
improved" household cleaner. 12 These tests are unnecessary both
because the products being tested are unnecessary for humans to
have, and because many such products are "new and improved"
versions of existing products whose toxic properties have already
been studied and are understood by researchers.
B. Loopholes in the AWA Allow Researchers to Avoid Applica-
tion of the Three R's in Practice
The second deficiency in the Three R's is that their incorpo-
ration in the AWA created significant loopholes that allow re-
searchers to avoid making changes in practice. Most signifi-
cantly, the AWA only applies to six species of animals used in
experiments: dogs, cats, nonhuman primates, rabbits, hamsters,
101 See Harold Herzog, et al, Social Attitudes and Animals, in Deborah J. Salem and
Andrew N. Rowan, eds, The State of Animals 61 (Humane Society 2001) (52% of those
surveyed approved of using monkeys in painful experiments to ensure that a new drug to
cure leukemia in children is safe; only 6% approved of using monkeys in painful experi-
ments to test whether an ingredient in cosmetics would be harmful to people). See also
Market & Opinion Research International, Use ofAnimals in Medical Research: Research
Study Conducted for Coalition for Medical Progress 26 (2005), available at
<http'//www.medicalprogress.orguploads/docs/CMPMORI_2005_Report. pdf> (last vis-
ited Feb 24, 2006) (76% of survey responders support animal experimentation "so long as
there is no unnecessary suffering.").
102 According to Tom Regan, some of the consumer products that researchers test on
animals include:
Insecticides, pesticides, antifreeze chemicals, brake fluids, bleaches, Christmas tree
sprays, church candles, silver cleaners, over cleaners, deodorants [sic], skin fresh-
eners, baby preparations, bubble baths, freckle creams, depilatories, eye makeup,
crayons, fire extinguishers, inks, suntan oils, nail polish, mascara, hair sprays and
rinses, zipper lubricants, paints, thermometers and children's novelties.
Tom Regan, The Case forAnimal Rights 369-70 (California 2d ed 2004).
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and guinea pigs. 103 It does not, however, apply to rats, mice,
birds, fish, or farm animals. Rats and mice are believed to ac-
count for up to 90% of the animals used in experiments"°; with
birds and fish added in, the figure may be as high as 97%.1°'
The exemption for these animals has long been implicit in
the AWA, but Congress did not codify it until 2002-suspiciously
soon after the U.S. Department of Agriculture, which adminis-
ters the AWA, finally agreed to include these animals within the
AWA's scope. 06 Federal research policies do cover rats, mice,
birds, fish, and farm animals, in addition to the animals covered
by the AWA, 1°7 but they do not cover all research facilities or
have the status of federal law.'
Even for those animals covered by the AWA, evidence sug-
gests that researchers are taking advantage of other loopholes to
avoid applying the Three R's. First, the AWA urges reductions,0 9
and Russell and Burch advocated better design and statistical
analysis of experiments as early as 1959.11' Yet one commentator
observed in 1994 that "Ir]elatively few attempts have been made
to assess the quality of design of animal experiments," and that
poor statistical methods are common and are "not confined to
toxicology.""' Possible reasons for the lack of reductions include
confidentiality concerns among competing researchers" 2 and lack
of ready access to information about prior experiments.
113
103 7 USC § 2132(g) (2000).
'" Orlans FB, Data on Animal Experimentation in the United States: What They Do
and Do Not Show, 37(2) Perspective Biology and Med 217, 218 (1994) (noting that the
AWA does not apply to mice, rats, and birds, which make up between 80-90% of all ani-
mals used in experiments); Francione, Introduction to Animal Rights at 34 (cited in note
9) ("[T]he Animal Welfare Act does not cover rats and mice .. .which, according to the
federal government, account for approximately 90% of the animals used.").
105 Rowan E-mail (cited in note 28).
106 See David Favre, Animals: Welfare, Interests, and Rights 361 (L & Hist 2003). See
also Francione, Animals, Property, and the Law at 211-33 (cited in note 9) (critiquing
USDA's enforcement of the AWA).
... See PHS Policy at 8 (cited in note 75) (defining an "animal" as "[a]ny live, verte-
brate animal used or intended for use in research, research training, experimentation, or
biological testing or for related purposes").
108 The PHS Policy is only applicable to research being conducted at a PHS facility or
otherwise funded by PHS, and violations of the PHS Policy at most result in the suspen-
sion or revocation of NIH funding. Id at 7. In contrast, the AWA applies to all research,
testing, or teaching involving animals covered by it regardless of the source of funding,
and violations can result in criminal and civil penalties for both the lead researcher and
the research facility. 7 USC § 2149 (2000).
109 See notes 67-68 and accompanying text.
110 See notes 22-23 and accompanying text.
"' Festing, Reduction ofAnimal Use at 213 (cited in note 23).
112 See Paul Rincon, Animal Efforts Need Bikger Push' (May 25, 2005), available at
<http:I/news.bbc.co.uk/l/hi/sci/tech/4575371.stm> (last visited Jan 12, 2006) (discussing
rivalry between scientific teams and commercial confidentiality as slowing information
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Second, the AWA purports to require refinements in the
form of pain relief, but it creates an exception for cases of "scien-
tific necessity."" 4 Research facility reports submitted pursuant to
the AWA suggest that researchers are frequently invoking this
exception. For example, in the most recent figures from 2004,
pain relief was withheld from 86,748 dogs, cats, nonhuman pri-
mates, rabbits, hamsters, and guinea pigs used in painful ex-
periments." 5 Animal advocates have argued that the limited
AWA figures are actually low because researchers underestimate
the number of experiments that cause pain or distress, choosing
to categorize only the most painful experiments as such. 116 Crit-
ics have also claimed that scientists lack a good understanding of
what causes pain and distress in animals, and instead simply
apply their knowledge of what causes pain and distress in hu-
mans, which may be underinclusive. 117 Even if the AWA reports
are accurate, 86,748 cases of "scientific necessity" in 2004 alone,
for what constitutes less than 10% of laboratory animals, make
this appear to be a significant exception that is allowing many
researchers to avoid making refinements in practice.
Finally, with regard to replacements, recall that the AWA
requires researchers to confirm to IACUCs that they have con-
sidered non-animal alternatives."' Beyond this, however, IA-
sharing).
' See Gill Langley, et al, Accessing Information on the Reduction, Refinement and
Replacement of Animal Experiments: Report and Recommendations of a Focus on Alter-
natives Workshop, 27 Alternatives to Lab Animals 239, 241-42 (1999), available at
<http'//www.focusonalternatives.org.uk/PDFs/Accessing%2Info.pdf> (last visited Jan 12,
2006) (The report quotes Britain's Chief Inspector of the Home Office as stating that
"important methodological 'tricks of the trade', as well as problems encountered, lessons
learned and refinements achieved, are often not published in papers. This deficiency,
together with the fact that published papers are not indexed by method, means that exist-
ing databases are difficult to use for finding information on the least severe protocols.").
114 See notes 63-65 and accompanying text.
11 Animal and Plant Health Inspection Service ("APHIS"), USDA, Animal Care Re-
ports: Annual Reports of Enforcement by F scal Year: 2004, available at
<http://www.aphis.usda.gov/ac/awreports/awreport2004.pdf> (last visited Feb 24, 2006)
(providing totals for animals experimented on in all years along with 2004 data). Similar
reports for every year are available in PDF under the Animal Care Reports heading of
APHIS' Animal Care Publications at <http'//www.aphis.usda.gov/ac/publications.html>
(last visited Feb 24, 2006).
116 See Mary T. Phillips, Savages, Drunks, and Lab Animals: The Researcher's Per-
ception of Pain, 1 Society & Animals 61, 74-76 (1993); Jonathan P. Balcombe, et al, Labo-
ratory Routines Cause Animals Stress, 43 Am Assn Lab Animal Sci 42 (Nov 2004).
117 See, for example, P.A. Flecknell, Refinement of Animal Usage-Assessment and
Alleviation of Pain and Distress, 28 Lab Animals 222, 222 (1994) ("The promotion of re-
finement of experimental techniques requires more than the adoption of uncritical an-
thropomorphic views. A critical approach based on careful assessment of pain and dis-
tress in animals is necessary.").
118 7 USC § 2143(b)(1)(B) (2000). See note 74 and accompanying text. Cal Civ §
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CUCs cannot interfere with the design or performance of an ex-
periment, so they appear to be bound to accept the researcher's
assertions that suitable non-animal alternatives do not exist.
Evidence of what occurs inside research laboratories is notori-
ously difficult to get."9 However, what evidence there is suggests
that replacements of animals with non-animal alternatives are
still uncommon. Consider toxicity testing, a field of research for
which non-animal alternatives have been developed. Some of
these alternatives have been validated by ICCVAM, while others
are now in the validation process. For instance, Corrositex and
other in vitro testing methods have been developed to assess the
potential of chemicals to cause skin corrosion, and four of these
methods have been at least partially validated by ICCVAM."2 °
Corrositex was validated in 1999, and has been accepted by nine
federal regulatory agencies, including CPSC, EPA, OSHA, and
FDA.
Corrositex replaces the "Draize" skin irritancy test that is
performed on rabbits and guinea pigs.' In the Draize tests, re-
searchers apply chemicals to the backs of rabbits or guinea pigs
and wrap the area for the first day to keep the chemicals in close
contact with the skin.2 2 These tests are highly painful and can
last for up to six hours a day, with tests on a single animal last-
ing up to three weeks.'23 Corrositex has many advantages over
the Draize test: it is easier and takes less time to perform,'124 is
1834.9(a) (2006) might be seen as an exception because it purports to require the use of
alternatives that have been validated, although there appear to be large loopholes in this
legislation. For a discussion of the legislation generally, see Stacy E. Gillespie, A Cover-
Girl Face Does Not Have to Begin with Animal Cruelty: Chapter 476 Gives Legal Force to
Alternative Testing Methods, 32 McGeorge L Rev 461 (2001).
119 See, for example, Francione, Introduction to Animal Rights at 34 (cited in note 9)
(noting that the Congressional Office of Technology Assessment stated that "[e]stimates
of the animals used in the United States [for research] each year range from 10 million to
upwards of 100 million'" but "concluded that 'all these data are unreliable' because 'every
estimate of animal use stands as a rough approximation'").
120 In addition to Corrositex, the three other non-animal alternatives to the Draize
skin irritancy tests that have been partially validated by ICCVAM are Murine Local
Lymph Node Assay ("LLNA"), EpiSkin, and Epiderm. NIEHS, About ICCVAM: Overview
(cited in note 88).
121 The "Draize" tests were named after their inventor, John Draize, a toxicologist who
headed the United States Dermal and Ocular Toxicity Branch of the FDA and developed
the tests in the early 1940s.
122 Francione, Introduction to Animal Rights at 45 (cited in note 9).
123 Id.
124 Draize skin irritancy tests can take up to two to four weeks to return the desired
results, whereas Corrositex can provide a determination of corrosivity in approximately
four hours. See Institute for In Vitro Sciences, Inc, Corrositex Continuous Time Monitor
Assay, available at <http://www.iivs.org/methods/CORROSTX-symbol.pdf> (last visited
Jan 7, 2006); E-mail from Martin Wolf, Chemist at Seventh Generation, to Nikia Fico
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less expensive to perform,12 5 yields generally equivalent re-
sults,126 and eliminates animal use. Yet few of the large con-
sumer products companies that perform corrosivity tests use or
rely on Corrositex or other non-animal alternatives, while many
still use the Draize tests.
127
In addition, several non-animal alternatives to eye irritancy
testing have shown great promise for replacing the Draize eye
(Jan 5, 2006) ("Wolf E-mail") (on file with author) ("Testing with in vitro methods is much
easier and less expensive than testing with animals. We have not encountered any limita-
tions except with regard to regulatory acceptance of the methods."); E-mail from Patti
Murphy, Consumer Dialogue and Services at Tom's of Maine, to Nikia Fico (Jan 5, 2006)
("Murphy E-mail") (on file with author) (Murphy quotes an in-house scientist as stating
"The in vitro tests we use are quite easy to perform-one can only assume they are easier
to perform than classical animal testing. Through a combination of using well-
characterized raw materials, in vitro testing, and finished product testing with volun-
teers, we have been able to consistently ensure the safety of our cosmetic products.").
125 MB Research Laboratories, which performs product safety testing for manufactur-
ers, charges $950 for one kit of Corrositex, which provides testing supplies to replace ten
Draize skin irritancy tests. MB Research Labs, 2006 Capabilities and Pices, available at
<http'//www.mbresearch.com/capabilities.pdf> (last visited Apr 30, 2006). By comparison,
it charges $1,750 to perform the same amount of testing on albino rabbits. Id. Further, a
recent evaluation done by InVitro International, a large provider of non-animal testing
methods, found that one of their customers saved up to $50,000 annually in shipping
costs for a single compound by using Corrositex instead of animals. InVitro International,
Corrositex, available at <http'J/www.invitrointl.com/products/corrosit.htm> (last visited
Feb 24, 2006).
126 Corrositex has an accuracy rate of 79% when compared to the rabbit skin corrosiv-
ity tests. ICCVAM, Corrositex: An In Vitro Test Method for Assessing Dermal Corrosivity
Potential of Chemicals 19 (NIH 1999). While this figure may appear to make Corrositex a
less desirable test than rabbit tests, this is not necessarily the case. Corrositex, because it
uses human skin cells, may produce better results than the rabbit tests in some cases,
and this could explain why there is not better or perfect correlation between the two. See,
for example, Siharath v Sandoz Pharmaceuticals, 131 F Supp 2d 1347, 1366 (N D Ga
2001) ("Extrapolations from animal studies are not considered reliable in the absence of a
credible scientific explanation of why such extrapolation is warranted.").
127 Companies such as Clairol, Inc, Procter & Gamble Co, Unilever United States, Inc,
Unilever Cosmetics Intl, Helene Curtis Intl, Lever Brothers Co, Colgate-Palmolive Co,
and SmithKline Beecham Plc continue to perform traditional animal testing despite the
availability of alternatives. See ARK, Animal Testing by the Cosmetic Industry, available
at <http://www.arkavailable.com/animaltest.html> (last visited Jan 12, 2006); NAVS,
Ammals in Product Testing. Who Is and Who Isn't Testing on Animals, available at
<http'J/www.navs.org/ sitefPageServer?pagename=ainpt whois> (last visited Jan 12,
2006). In fact, Proctor & Gamble went so far as to lobby against the passage of legislation
in California that would have banned the Draize test. See In Defense of Aimals, Procter
& Gamble: Facts, available at <www.idausa.org/facts/pg.html> (last visited Jan 12, 2006);
Animal Liberation Victoria, Procter and Gamble, available at <http'J/home.vicnet.net.au
/-animals/alibvic/procter.htm> (last visited Jan 12, 2006) ("In 1990, Procter & Gamble
lobbied against legislation to ban the Draize test in California.").
On the other hand, companies such as Seventh Generation, Tom's of Maine, and
Ecover exclusively use alternatives to the Draize tests. Wolf E-mail (cited in note 124);
Murphy E-mail (cited in note 124); E-mail from Caroline Broeckx, Ecover Belgium, to
Nikia Fico (Dec 23, 2005) (on file with author) (stating that Ecover never uses Draize
testing but does use the non-animal alternatives).
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irritancy test and are now in the ICCVAM validation process. 118
These include Epi~cular, an in vitro model produced by the com-
pany MatTek. 129 Epi~cular replaces the Draize eye irritancy test
that is performed on rabbits, often albinos because of their large,
clear eyes.3 ° In the Draize tests, rabbits are physically re-
strained while and after chemicals are applied to their eyes.
Rabbits have fewer tear ducts than do humans, and they do not
have blink reflexes, so they cannot flush out the chemicals. These
tests are highly painful, and rabbits have been known to break
their backs struggling to escape their restraints. Like Corrositex,
Epi~cular has many advantages over the Draize eye test: it is
easier and takes less time to perform, 131 yields generally equiva-
lent results,132 and eliminates animal use. Unlike Corrositex,
however, Epicular is currently more expensive to perform than
the Draize test.3 3 Despite its net advantages, few of the large
"2 Alan M. Goldberg and Thomas Hartung, Protecting More Than Animals, Scientific
Am 84, 91 (Jan 2006):
The replacement effort faced a major setback in the early 1990s, when six large vali-
dation trials for alternatives to the Draize eye test failed. The outcome was puzzling,
since some of the alternatives were being used in the cosmetics industry without ap-
parent problems. Having reviewed other data, we now understand why the alterna-
tives failed: their results were being compared with those of the Draize test itself,
which, it turns out, yields many false positives. ICCVAM ... [is] now reviewing ex-
isting information on the Draize test and its alternatives. The study will form the
basis of a statement of validity or, if necessary, another validation trial of Draize al-
ternatives, and this time we are reasonably confident of success.
129 NIEHS, Epicular OCL-200, available at <http://iccvam.niehs. nih.gov/methods/
epioctox.htm> (last visited Apr 30, 2006). Other non-animal alternatives to eye irritancy
testing include Bovine Corneal Opacity and Permeability Assay ("BCOP"), Isolated
Chicken Eye Assay ("ICE"), Isolated Rabbit Eye Assay (IRE), and the Hen's Egg Test or
Chorioallantoic Membrane Assay ("HET-CAM"). NIEHS, About ICCVAM: Overview
(cited in note 88).
3o See Francione, Introduction to Animal Rights at 45 (cited in note 9) ("Albino rab-
bits are normally used for these tests because their eyes are large, clear, and easily ob-
servable, and because the tearing of their eyes, appreciably less than that of other ani-
mals' eyes, does not wash away or dilute the substance to be tested.").
131 EpiOcular results can usually be obtained in three minutes to an hour, as com-
pared to three to eighteen days using the traditional Draize eye irritancy test. See Mat-
Tek Corp, Ocular Irrtation Protocol: Neat Method (MTT ET-50) for Use with EpiOcu-
larTM Tissue Model (OCL-200) 2 (2005) (on file with MatTek) (MatTek unpublished proto-
col method); Wolf E-mail (cited in note 124) (noting relative ease of performing alterna-
tive tests); Murphy E-mail (cited in note 124) (same).
"32 EpiOcular has up to a 93% correlation rate with the Draize eye irritancy test and
can even be used to differentiate between materials which are too mild for the Draize test
to distinguish. MB Research Labs, The Epi~cular Prediction Model: In Vivo Versus In
Vitro Draize Scores for Consumer Products, available at <http:J/www.mbresearch.com/
epi-pre.htm> (last visited Apr 30, 2006) (finding that when a single outlier is excluded
from the calculation, the correlation rate between Epicular and the Draize eye irritancy
test raises from 85% to 93%).
13 For a full assay done with EpiOcular, MB charges $2,100, whereas the equivalent
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consumer products companies that perform corrosivity tests use
or rely on Epi~cular or the other non-animal alternatives, while
many still use the Draize tests.
3 4
It is unclear why large consumer products companies still
use the Draize animal tests to measure corrosivity. In research-
ing this Article, many of these companies were contacted in an
attempt to shed light on this, but none responded. 135 The publicly
available information from company websites and other sources
are sparse on details of animal testing, for obvious reasons. 136
Perhaps these companies still use the Draize test only to fill
in the holes left by the imperfections of non-animal alterna-
tives,'37 or because in some instances animal tests are still re-
quired by law. 38 More likely reasons, however, are comfort with
the traditional animal model, the vested interests of institutional
players in animal research, 139 fear of deviating from the status
Draize test (called "Acute Eye Irritation in Rabbits") costs $945 for three days of tests on
three animals, with a cost of $60 for each additional day of testing. Email from Traci
Fletcher, MB Research Labs Client Services, to Susie Cowen (Apr 19, 2006) (on file with
The University of Chicago Legal Forum).
134 See sources cited in note 127. But see MatTek Corporation, In Vitro Alternative to
Draize Test, available at <httpJ/www.mattek. com/pages/products/epiocular/draize
-alternative> (last visited Jan 5, 2006) (claiming that Colgate-Polmolive, Procter & Gam-
ble, and Unilever all use their EpiOcular alternative "to replace some/all of their tradi-
tional Draize (rabbit) ocular irritation testing").
13 E-mail from Nikia Fico to Abbott Labs, contacted through their website (Dec 23,
2005) (on file with author); E-mail from Nikia Fico to Bristol Myers Squibb, contacted
through their website (Dec 23, 2005) (on file with author); E-mail from Nikia Fico to Col-
gate-Palmolive, Co, contacted through their website (Dec 23, 2005) (on file with author);
E-mail from Nikia Fico to Gillette, contacted through their website (Dec 23, 2005) (on file
with author); E-mail from Nikia Fico to Johnson & Johnson, contacted through their
website (Dec 23, 2005) (on file with author); E-mail from Nikia Fico to Pfizer, contacted
through their website (Dec 23, 2005) (on file with author); E-mail from Nikia Fico to Proc-
tor & Gamble, contacted through their website (Dec 23, 2005) (on file with author); E-
mail from Nikia Fico to The Clorox, Co, contacted through their website (Dec 23, 2005)
(on file with author); E-mail from Nikia Fico to Unilever, contacted through their website
(Dec 23, 2005) (on file with author).
136 Johnson & Johnson provides more information than most. See
<httpJ/www.jnj.com/community/policies/animal testing/statement.htm> (last visited Jan
28, 2006) ("We have modified the standard test method for eye irritation, the Draize eye
test, to reduce the number of animals per test. We have modified the standard Draize
skin irritation test to require fewer animals, and we rely heavily on studies in human
volunteers.").
"' Carmen Fleetwood, In Vitro Testing is the New Guinea ffg, Wall St J B2B (Sept
29, 2004) ("One limitation of MatTek's tests is that they don't demonstrate how a drug or
treatment will interact with other organs, according to Mitch Klausner, vice president of
scientific affairs at MatTek. This limitation is on of the reasons the company's tissue
models are unlikely to fully replace animal testing.").
138 For example, the law still requires animal tests for substances classified as a "pes-
ticide." 40 CFR 158.34 (2005). But the question remains why a cleaning product from one
company, for example, receives this classification when more progressive companies are
developing products that accomplish the same purpose and avoid it.
139 Balls, Replacement of Animal Procedures at 200 (cited in note 32) ("The mainte-
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quo and the legal liability that may accompany that decision, 4 °
and irrational insistence on high-fidelity models.' For academic
researchers, the pressure to publish may be a factor, as far more
papers can be published in a given time period if animal experi-
ments are used.'42 It is also the case that viable alternatives do
not yet exist for many experiments and tests involving animals.
Here, the research community and the federal government can
be criticized for lax funding for alternatives compared to the
funding they devote to animal research.'
nance of the status quo [in toxicity testing] is backed by enormous vested interests-in
the regulatory authorities, in industry, in academia, and in contract testing establish-
ments.").
140 Id at 201 ("Validation is difficult and the hurdles placed in the path of replacement
alternatives must be high... if mistakes are to be avoided."). On the issue of legal liabil-
ity, see, for example, Sibarath, 131 F Supp 2d at 1367 (noting that a "few courts have
been more amendable to the use of animal studies in proving causation, at least pre-
Daubert" but rejecting the use of animal studies for that purpose in that case).
141 Balls, Replacement of Animal Procedures at 203 (cited in note 32) (noting in 1994
that "[w]hat Russell and Burch said about the emotional weight acquired by the high
fidelity fallacy when the demands of public health and safety are involved... remains as
true today as it did in the 1950s!"). See also notes 38-41 and accompanying text.
142 Greek and Greek, Sacred Cows and Golden Geese at 79 (cited in note 32):
Not only [are they] easier, animal experiments are also much quicker than human
studies. A rat's generation time is weeks, not decades. By the time a clinician pub-
lishes one good paper, an animal experimenter can publish at least five. The easiest
way to publish is to take a concept already published and change something, the
type of animal used, the dose of the drug, the method of assessing the results, or
some other variable. This way, the concept has already been milled and all the re-
searcher has to do is follow the template with new grist.
For a discussion of the resistance to the Three R's among the academic research
community, see note 58 and accompanying text.
14 For instance, the Wall Street Journal reports that Proctor & Gamble devotes only one
percent of its annual research budget to alternatives. See Fleetwood, In Vitro Testing is
the New Guinea Pg, Wall St J at B2B (cited in note 137) (noting, seemingly with favor,
that Proctor & Gamble devotes $10-$13 million of its annual $1 billion research budget to
the development of alternatives). Government funding in the U.S. is also woefully defi-
cient. See Goldberg and Hartung, ProtectingMore Than Animals at 90 (cited in note 128).
Goldberg an Hartung state:
Finding funds for research specifically directed at alternatives has been difficult, at
least in the U.S. The National Toxicology Program, which coordinates all toxicologi-
cal testing programs within the federal government, together with the National In-
stitutes of Environmental Health Services, provides the bulk of government funding
for alternatives. Although the U.S. government's agencies are interested in humane
science, they have spent less than $10 million over the past decade on validating al-
ternatives for regulatory use. Id.
Government funding is only moderately better in Britain, where there is signifi-
cantly more opposition to the use of animals in experiments than in the U.S. For example,
although a negative report on laboratory animal use and treatment prompted the British
government to award three million pounds to the National Centre for the Replacement,
Refinement and Reduction of Animals in Research for the years 2006-2008, even moder-
ate animal welfare organizations described this funding as a "drop in the ocean." See
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C. The Three R's Have No Application to New and Emerging
Technologies
The third major deficiency of the Three R's is that they were
not designed with new and emerging technologies in mind. The
Three R's attempt to reduce, refine, and replace existing and ar-
chaic uses of animals that are no longer needed given a non-
animal alternative. They were not designed to apply to "cutting-
edge" technologies that will be first tried out on animals.
This design deficiency in the Three R's manifests itself
through the way in which potential replacements are evaluated.
Non-animal alternatives are typically evaluated by comparing
data produced by using the alternative with data produced by
traditional animal tests.'" For instance, the ICCVAM has to date
validated only sixteen alternatives and partially validated only
four non-animal alternatives, including Corrositex. 1" The appli-
cations for each of these alternatives compared data produced by
the alternative with data produced by traditional animal tests,
with the alternatives yielding generally equivalent results.'46
This method of evaluating non-animal alternatives is prob-
lematic on multiple levels, all of which suggest that the accep-
Rincon, Animal Efforts (cited in note 112) (quoting the science manager of the animal
advocacy organization FRAME).
144 See 42 USC § 2851-4(b) (2000) (stating that alternatives to be promoted and en-
couraged "if such test methods are found to be effective for generating data, in an amount
and of a scientific value that is at least equivalent to the date generated from existing
tests"); Andrew Rowan, The Alternatives Concept, available at <http://www.nal.usda.gov/
awic/aternatives/rowan.htm> (last visited Jan 12, 2006) ("[A]ny valid alternative system
must provide data which leads to the same conclusion with at least the same degree of
confidence as that obtained from the system being replaced."). The exception is where a
body of data from human experiments is available for comparison purposes, but this is
uncommon.
1" See About ICCVAM- Overview (cited in note 88) (discussing alternatives to certain
toxicity tests); E-mail from Brad Blackard to Nikia Fico (Jan 12, 2006) (on file with au-
thor).
", The Murine Local Lymph Node Assay ("LLNA"), an alternative to guinea pig as-
says to determine the potential of chemicals to cause allergic reactions, performed equiva-
lently with the traditional animal test for identification of strong to moderate chemical
sensitizing agents, correlating with the guinea pig assays 88% of the time. ICCVAM, The
Murme Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Der-
matitis Potential of Chemicals/Compounds 13 (NIH 1999). Corrositex, discussed earlier,
had an accuracy rate of 79% when compared to the rabbit skin corrosivity tests. ICCVAM,
Corrositex: An In Vitro Test Method forAssessing Dermal Corrosivity Potential of Chemi-
cals 19 (NIH June 1999). EpiSkin and EpiDerm, in vitro human skin cell culture model-
ing systems for dermal corrosivity testing, both had a 83% correlation rate to the Draize
skin irritancy test. ICCVAM, Recommended Performance Standards for In Vitro Test
Methods for Skin Corrosion 27 (NIH May 2004). As discussed in note 126, in vitro tests
using human cells may produce better results than animal tests in some cases by remov-
ing the extrapolation difficulties present in the latter. This could help to explain why
there is not better or perfect correlation with animal tests.
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tance of an alternative will be the exception rather than the rule.
First, it is far from certain that the benchmark for comparison,
the animal data, is reliable due to extrapolation problems. Many
scientists, animal advocates, and even courts have lodged this
objection.'47 Second, while toxicity testing often lends itself to
this evaluation process, biomedical research does not. As Rowan
explains:
Diagnosis and toxicity testing are somewhat different ac-
tivities from basic and applied research. In both diagnosis
and toxicity testing, the techniques used are not subject to
much change.... However, in basic and applied research,
the investigator is likely to vary the technical approach
considerably from one project to the next. In addition, the
investigator may need to use more than one technique to
resolve a particular question to the satisfaction of his or
her peers. As a result, it is usually much easier for those
who are promoting the idea of alternatives to focus on
such areas as diagnosis and toxicity testing.48
Third, animal data will not be available for comparison pur-
poses in new and emerging fields of research. As one commenta-
tor states, "where a new method is developed to identify new ef-
fects not previously tested or well defined, there is no paradigm
147 See, for example, Kathy Archibald, Animal Testing: Science or Fiction, available at
<http://www.theecologist.co.uk/currentissue/ animal-testing.htm> (last visited Jan 5,
2006) (stating that the Handbook of Laboratory Animal Science admits that "uncritical
reliance on the results of animal tests can be dangerously misleading and has cost the
health and lives of tens of thousands of humans"); Marlene Cimons, Cancer Drugs Face
Long Road From Mice to Men, LA Times Al (May 6, 1998) (The article quotes Dr Richard
Klausner, former director of the U.S. National Cancer Institute ("NCI"): "The history of
cancer research has been a history of curing cancer in the mouse. We have cured mice of
cancer for decades, and it simply didn't work in humans."); Sabin, Remarks, Statement
before the subcommittee (cited in note 32) ("[The polio vaccine] was long delayed by the
erroneous conception of the nature of the human disease based on misleading experimen-
tal models of [it] in monkeys."); Regan, The Case for Animal Jghts at 371 (cited in note
102) ("Animal toxicity tests of products can be, and have been, challenged on the basis of
their limited scientific validity. The problem of extrapolating test results from animals to
human is notorious.") (citation omitted); Greek and Greek, Sacred Cows and Golden
Geese at 58-76 (cited in note 32) (questioning validity of animal-modeled drugs); Si-
harath, 131 F Supp 2d at 1366-67:
First, extrapolating from animals to humans is difficult because "differences in ab-
sorption, metabolism, and other factors may result in interspecies variation in re-
sponses." . . . Second, the "high doses customarily used in animal studies requires
consideration of the dose-response relationship and whether a threshold no-effect
does exist." (citations omitted).
"1 Rowan, Of Mice, Models, & Men at 271 (cited in note 5).
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with which to compare the effectiveness of the alternative. " 119
Underlying these problems is the fact that the evaluation of non-
animal alternatives typically requires a stable usage situation-
in other words, a well-developed technique that many research-
ers employ.
A stable usage situation will not be present in new and
emerging areas of research, including the use of animals for stem
cell research, cloning, xenotransplantation, genetic modification,
and bioterrorism defense.15° These areas of research have the
potential to greatly escalate the use of animals in experiments
and the suffering that these animals are made to endure."'
Stem cell research promises to be a focal point of biomedical
research in the twenty-first century. This research will involve
surgically inserting human and animal stem cells into animals to
monitor the effects.152 What will happen to the recipients of the
stem cells is unknown, which is why animals will be the first ex-
perimental subjects. As a 2005 opinion piece in the New York
Times stated, "[c]learly it is unethical to study the unknown ac-
tions of stem cells in human subjects. One obvious solution is to
insert the cells into animals and watch how they develop."'5 3
"' Gallagher, Toxicity Testing Requirements at 264 (cited in note 80).
..0 While some of these technologies have been explored in the past (for example,
xenotransplantation and the use of animals for bio-agents research), this Article refers to
them as "new" technologies because they are becoming prominent or widely studied only
now.
' See Rudacille, The Scalpel and the Butterfly at 205 (cited in note 5). Rudacille
explains:
[A] group of new technologies that necessarily involve extensive use of animals has
the potential to reignite the [animal experimentation] debate. Xenotransplantation,
in which organs and tissues from animal donors are transplanted into human hosts,
and transgenic technology, which adds or deletes genes or transfers genetic material
between species, are two types of research that have raised questions and concerns
among some scientists and bioethicists. Even more controversy surrounds a related
development, still in its infancy but already a source of considerable discussion: so-
matic cell nuclear transfer, popularly known as cloning. All of these use significant
numbers of animals in research programs that deserve careful scrutiny. But most of
the debate thus far, both within the scientific community and among bioethicists and
policymakers, has focused on the possible implications of these evolving technologies
for human beings, with relatively little discussion of their impact on animals or the
linkages between the two.
152 See, for example, Jamie Shreeve, The Other Stem-Cell Debate, NY Times 6-42
(Apr 10, 2005) (describing invasive stem cell experiments being performed on monkeys on
the Caribbean island of St. Kitts in the hopes of curing Parkinson's disease, and stating
"[d]riving the surge in chimeric experimentation is the enormous but still untested prom-
ise of human stem cells").
153 Id.
224 THE UNIVERSITY OF CHICAGO LEGAL FORUM [2006:
While some animal advocates view stem cell research as an
alternative to animal experimentation, 15 4 that is an inaccurate
characterization. Stem cell research will involve the use of hun-
dreds, thousands, or potentially even millions of animals in ex-
periments as it develops. However, the ethics of using animals in
these experiments, and a discussion of whether the suffering of
animals will outweigh the benefits to humans, has so far been a
footnote to religious objections over destroying human em-
bryos.'55 Any objections that have been made have focused on the
possibility of producing "chimeras"'56 with human-like conscious-
ness, which could be viewed as an anthropocentric concern. '
Indeed, only the chimera concern is reflected in the Guidelines
for Human Embryonic Stem Cell Research recently published by
the National Academy of Sciences. 5 '
Cloning is another new and rapidly emerging technology
that will involve significant animal use. As Rudacille states,
"all... possibilities [for cloning] must be extensively researched
" See Jean Swingle Greek and C. Ray Greek, What Will We Do If We Don't Experi-
ment on Animals? Medical Research for the Twenty-first Century 95-101 (Trafford 2004)
(describing stem cell research as a "new frontier in in vitro technology"); Stem Cell Re-
search: Moving Beyond Vivisection, available at <http'/www.peta.org/mc/factsheetdis-
play.asp?ID=128> (last visited Apr 30, 2006) (supporting stem cell research, but recogniz-
ing that it "currently involves animals"). See also Kim Stallwood, Editor's Agenda, Ani-
mals' Agenda 5 (Sep/Oct 2001). Stallwood states:
Curiously, throughout this very public discussion about science and ethics [over stem
cell research], there was mostly silence from the animal rights community, at least
with regard to media reports and congressional debate. No organization (that I heard
of) interjected an opinion about whether stem-cell research might ultimately reduce
the use of animals in similar research, or whether vivisection might even increase
based on efforts to "prove" in animals what might first be observed in stem-cell tests.
-' See John A. Balint, Ethical Issues in Stem Cell Research, 65 Alb L Rev 729, 733
(2002) ("There is generally very little concern about research with non-human embryonic
or'adult stem cells and there are few ethical concerns regarding plans for research with
human stem cells obtained from adults."). Consider James J. McCartney, Embryonic
Stem Cell Research and Respect for Human Life: Philosophical and Legal Reflections, 65
Alb L Rev 597 (2002) (discussing ethical and legal issues with the use of stem-cells from
adults, embryos, and umbilical cords).
156 See Shreeve, The Other Stem-Cell Debate, NY Times at 6-42 (cited in note 152)
(The article explains that a chimera is "an organism assembled out of living parts taken
from more than one biological species. The word comes from the monstrous creature of
Greek mythology-part lion, part serpent and part goat.").
157 See, for example, Nicholas Wade, Chimeras on the Horizon, But Don't Expect
Centaurs, NY Times Fl (May 3, 2005) (discussing potential moral issues raised by crea-
tion of chimeras).
" See Guidelines for Human Embryonic Stem Cell Research, Executive Summary 8,
available at <http://www.nap.edu/execsumm_pdf/11278.pdf> (last visited Jan 12, 2006)
(refusing to permit "[r]esearch in which [human embryonic stem cells] are introduced into
nonhuman primate blastocysts" because of the fear of producing animals with human-like
consciousness).
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and tested in animals before being applied to human popula-
tions."159 Cloning is directly related to stem cell research16 ° and to
xenotransplantation, which is discussed below.'61 Despite much
time, effort, money, and animal use by researchers, cloning re-
mains an extremely inefficient process with an average survival
rate of a mere 0.5%-4.0%, even for previously cloned species. 16
2
Cloning also causes significant animal suffering, both for the
cloned animals and their mother-carriers. In a 2001 New York
Times article, a researcher described her cloning portfolio as a
"gallery of horrors" that provided "a seldom-heard cautionary
tale."'63 Cloned embryos often grow excessively large in the
mother's uterus and require a caesarean section operation. This
mutation occurs so often that it has been dubbed "large offspring
syndrome.""6 It has also been observed that "cloned embryos fre-
quently carry profound deformities which result in markedly
high rates of abortion. Cloned animals also appear to exhibit se-
rious health problems, including early death and serious failures
of their organs as they grow."'65 As with stem cell research, Ru-
1' Rudacille, The Scalpel and the Butterfly at 206 (cited in note 5).
160 See Guidelines for Human Embryonic Stem Cell Research at 2 (cited in note 158).
The advantage of using [cloning] to derive hES [human embryonic stem cells] is that
the nuclear genomes of the resulting hES cells would be identical with those of the
donors of the somatic clls. One obvious benefit is that this would avoid the problem
of rejection if cells generated from the hES cells were to be transplanted into the do-
nor. Id.
161 See notes 167-74 and accompanying text.
162 See Lesley Paterson, et al, Application of Reproductive Biotechnology in Animals:
Implications and Potential Applications of Reproductive Cloning 79 Animal Reproduction
Sci 137, 142 (2003) ("Four years since [the cloning of Dolly]... cloning remains an ineffi-
cient process with typically 0.5-5% of embryos becoming viable offspring."); Gina Kolata,
In Cloning, Failure Far Exceeds Success, NY Times F1 (Dec 11, 2001) ("A vast majority of
[cloning] efforts fail, even in species that have at one time or another been cloned.").
163 Kolata, In Cloning, NY Times at F1 (cited in note 162).
'6 Joyce D'Silvia, Farm Animal Genetic Engineering and Cloning 3 (2002), available
at <httpi//www.ciwf.org.uk/publications/reports/farm-animal-genetic-engineering-and-
cloning-summary_2002.pdf> (last visited Jan 12, 2006). See also Uncaged, Interim Re-
sponse To: Emerging Biotechnologies and the Animals (Scientific Procedures) Act 1986,
available at <http'/www.uncaged.co.uk/biotech.htm> (last visited Jan 12, 2006). Apart
from the suffering and death caused by cloning techniques themselves, the production
process itself is cruel. According to Dr Mae-Wan Ho:
The animal is made to lactate early with hormone treatment and thereafter is kept
lactating permanently in order to keep up production. The protein the animal has to
produce is in addition to all the normal proteins in her milk, which in transgenic
sheep like Tracy [a genetically-modified forerunner of Dolly] ... is more than twice
as much protein as in ordinary sheep milk. So she is under permanent metabolic
stress. Id.
This kind of overproduction is known to cause mastitis, lameness, general malaise and
exhaustion in dairy cows.
16' BUAV, Animal Biotechnology: An Overview 3 (2004), available, at
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dacille notes that "the issue of animal welfare has largely been
ignored in public discussions about cloning. "166
A third new technology, xenotransplantation, seeks to har-
vest animal organs and transplant them into humans to replace
defective human organs. Animals are used in this process be-
cause of a lack of human organ donors.'67 Inter-animal trans-
plants are often used to develop and refine the process. 6 ' How-
ever, the experiments have not yet been successful because hu-
man immune systems consistently reject the animal organs,
treating them as invading organisms.169 Efforts have shifted to
producing cloned and transgenic animals, such as pigs altered
with human DNA, in the hopes of tricking the human body into
accepting the animal organ."o The "end goal is to create a living
production line of these partially humanized pig organs to use as
spare parts for humans."'7'
Xenotransplantation can cause significant animal suffering.
For example, reports tell of one baboon "which had a piglet heart
transplanted into its neck and for several days was observed
holding the heart, which was swollen and seeping blood and pus
as a result of infections from the wound. The animal also suf-
fered body tremors, vomiting, [and] diarrhea." 72  Notably,
<http://www.eceae.org/factsheets/GlAnimalBiotechnology.pdf> (last visited Jan 12,
2006).
"6 Rudacille, The Scalpel and the Butterfly at 229 (cited in note 5).
167 See Jack M. Kress, Xenotransplantation: Ethics and Economics, 53 Food Drug L J
353, 356 (1998) (outlining specific organ shortages).
'" Consider Frontline, Organ Farm, available at <http://www.pbs.org/wgbh/pages/
frontline/shows/organfarm> (last visited Jan 12, 2006) (describing and supplementing a
PBS documentary on xenotransplantation).
169 See Kress, Xenotransplantation at 364 (cited in note 167) ("Medical research inter-
est so far has centered on overcoming the body's natural immune system mechanisms
that lead to organ rejection.").
170 See Rudacille, The Scalpel and the Butterfly at 228 (cited in note 5) ("By using
transgenic technology, it might be possible to transfer rat genes into [a] mouse before
xenotransplantation, to 'trick' the rat's body into accepting the foreign tissue indefi-
nitely."); Gary Francione, Cloning Breeds Contempt and Adulation, Chi Trib 23 (Mar 7,
1997) ("With complete knowledge of the genome sequence, companies ... will acquire an
even broader range of profitmaking applications, such as the ability to combine greater
genetic knowledge with the cloning process to produce animals with 'human' organs.
These 'animals' could then serve as 'organ factories' for xenografts and cross-species
transplants."); Kolata, In Cloning, NY Times at Fl (cited in note 162) ("They also are
cloning to genetically modify animals so that humans can use their organs."). See also
Frontline, Organ Farm: Synopsis, available at <http://www.pbs.org/wgbh/pages/front-
line/shows/organfarm/etc/synopsis.html> (last visited Jan 12, 2006) ("Because a human
body would immediately reject a pig organ as foreign, these 'transgenic' pigs are geneti-
cally altered with human DNA in the hope that a human recipient's body will be fooled
into thinking the organ is human.").
171 Id.
172 Frontline, Organ Farm: Animal Welfare and Animal Rights, available at
<http://www.pbs.org/wgbh/pages/frontline/shows/organfarm/rights> (last visited Jan 12,
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xenotransplantation is unique among the new technologies be-
cause it inherently requires high-volume animal use for suc-
cess."7 3 Therefore, the Three R's would have little or no applica-
tion to xenotransplantation even if one day it were to present a
stable usage situation.'74
Researchers are genetically modifying animals for purposes
ranging from those discussed above to use of transgenic animals
in artwork. 76 Commentators observe that "it is vital that par-
ticular attention be paid to proposals to develop and use trans-
genic animals as models for human disease. [As] this rapidly-
developing field affords great scientific opportunities, but also
threatens to greatly increase laboratory animal suffering. " 176
Also, they note that "techniques used in biomedical research for
the production of transgenic animals have several implications
for animal welfare in terms of the Three Rs of Russell & Burch..
• [a]ll of these actual and potential implications for animal wel-
fare demand serious consideration within a broad ethical analy-
sis of the technology." 77
Finally, researchers are dramatically increasing the use of
animals in bioterrorism experiments after the terrorist attacks of
September 11, 2001 and subsequent anthrax attacks. HSUS re-
ports that the number of grants for bioterrorism research in-
2006).
17' Rowan, a supporter of the Three R's approach, concedes that "[t]he concept of al-
ternatives will not, if enthusiastically applied, result in the immediate cessation of ani-
mal experimentation. In many areas of research a problem can only be investigated by
means of an intact animal." Rowan, Of Mice, Models, & Men at 261 (cited in note 5).
174 Cognitive ethology is another area of increasing interest to researchers that inher-
ently involves the use of animals, although it is of a different nature than the other tech-
nologies discussed in this section. Marc Bekoff defines cognitive ethology as "the evolu-
tionary and comparative study of nonhuman animal .. thought processes, consciousness,
beliefs, or rationality, [and] is a rapidly growing field that is attracting the attention of
researchers in numerous and diverse disciplines." Marc Bekoff, Cognitive Ethology and
the Explanation ofNonhuman Animal Behavior, in Herbert L. Roitblat and Jean-Arcady
Meyer, eds, Comparative Approaches to Cognitive Science 119, 119 (MIT 1995). While
some of this research occurs by observing animals in their natural habitats, it also occurs
in laboratories. Bekoff and Dale Jamieson have discussed the ethical implications of this
research and the animal suffering that it causes. Dale Jamieson and Marc Bekoff, After-
word: Ethics and the Study of Animal Cognition, in Marc Bekoff and Dale Jamieson, eds,
Readings in Animal Cognition 359 (MIT 1996). Indicative of this suffering is one re-
searcher's experiment observing mother Norwegian rats and their pups chase and kill
mice in a contained enclosure. For a description of this experiment, see Bennett G. Galef,
Jr., Tradition in Animals: Field Observations and Laboratory Analyses, in Bekoff and
Jamieson, eds, Readings in Animal Cognition 95-96 (MIT 1996).
17 See Genetic Technologies and Animals, 20 AI & Soc 1 (2006), available at
<http'/www.eciad.bc.ca/-gigliott/gtanimal/TOC.htm> (last visited Jan 12, 2006).
178 Balls, Replacement ofAnimal Procedures at 198 (cited in note 32).
177 Collin J. Moore and T. Ben Mepham, Trangenesis andAnimal Welfare, 23 Alterna-
tives to Lab Animals 380 (1995).
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creased from 338 in 2003 to 661 in 2004.78 According to HSUS,
these experiments will subject "tens of thousands" of animals to
"Category A" pathogens including "anthrax, botulism, tularemia,
smallpox, [and] plague."'7 9 Many of these animals will be non-
human primates. According to two scientists, "[a]n increased
demand for nonhuman primates will undoubtedly characterize
the new era in which bioterrorism has become a reality."8 ° Like
the stem cell, cloning, xenotransplantation, and genetic modifica-
tion experiments discussed in this section, bioterrorism research
may produce few actual human benefits yet cause a large num-
ber of animals to experience tremendous suffering. But the Three
R's cannot be used to police any of these experiments, which are
newly emerging and thus do not present a stable usage situation.
CONCLUSION
Animal experimentation provides a good test of whether
animal use can be meaningfully regulated. In the past twenty
years, the Three R's have become the primary mechanism for
that regulation, having been incorporated into both federal law
and research policy. This Article has taken a systematic look at
the Three R's and has concluded that they fail in several re-
spects. These failures will become even more apparent as re-
searchers escalate the use of animals for stem cell research, clon-
ing, genetic modification, xenotransplantation, and bioterrorism
defense.
In her recent book on the history of animal experimentation,
Deborah Rudacille observed that "the war between antivivisec-
tion and animal research has given way to a tenuous truce-at
least between the parties willing to accept the Three R's solution
proposed by Russell and Burch." 8' Animal advocates should
break that truce and seek to abolish animal experimentation on
moral grounds, rather than ceding the practice and attempting to
178 HSUS, Code Orange for Animals in Bioterrorism Research (Mar 7, 2003), available
at <http"/www.hsus.org/animals-inresearch/animalsinresearch-news/code-orange-
foranimalsin_bioterrorismresearch. html> (last visited Jan 12, 2006).
179 Id.
ISO Jean L. Patterson and Ricardo Carrion, Jr., Demand for Nonhuman Primate Re.
sources in the Age of Biodefense, 46 Inst Lab Animal Rsrch J 15, 15 (2004), available at
<httpJ/dels.nas.edu/ilarn/ilarjournall46_l/pdfs/v460lPatterson.pdf> (last visited Jan 12,
2006). The research community is openly concerned about the availability of nonhuman
primates for purposes of conducting bioterrorism and other research, recently holding a
conference entitled International Perspectives: The Future of Nonhuman Primate Re-
sources, Proceedings of the Workshop Held April 17-19, 2002, National Academy of Sci-
encesAuditorium, Washington, D.C. (Natl Academy 2003).
181 Rudacille, The Scalpel and the Butterfly at 269 (cited in note 5).
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regulate it. Regulation is ineffective, even under favorable condi-
tions-it provides false comfort that we can use animals for our
purposes without them suffering in the process. An abolitionist
approach, while more of an uphill battle, is the only way to pre-
vent animals from suffering in our laboratories and beyond.
